Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-052044
Filing Date
2020-09-24
Accepted
2020-09-24 21:39:33
Documents
1
Period of Report
2020-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5915
  Complete submission text file 0001209191-20-052044.txt   7452
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 INDIAN HOLLOW ROAD MENDHAM NJ 07945
Business Address
Lingnau Lutz (Reporting) CIK: 0001354179 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 201196675